Association of neutrophils and future cardiovascular events in patients with peripheral artery disease Markus Haumer, MD, Jasmin Amighi, MD, Markus Exner, MD, Wolfgang Mlekusch, MD, Schila Sabeti, MD, Oliver Schlager, MD, Ilse Schwarzinger, MD, Oswald Wagner, MD, Erich Minar, MD, Martin Schillinger, MD Journal of Vascular Surgery Volume 41, Issue 4, Pages 610-617 (April 2005) DOI: 10.1016/j.jvs.2005.01.013 Copyright © 2005 The Society for Vascular Surgery Terms and Conditions
Fig 1 A, Cumulative event-free survival defined as freedom from myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, any stroke, carotid revascularization and death, and (B) cumulative survival in 398 patients according to the baseline neutrophil count (in tertiles). Journal of Vascular Surgery 2005 41, 610-617DOI: (10.1016/j.jvs.2005.01.013) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions
Fig 2 Cumulative event-free survival, defined as freedom from myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, any stroke, carotid revascularization and death, in 398 patients according to baseline eosinophils, basophils, lymphocytes and monocytes (in tertiles). Journal of Vascular Surgery 2005 41, 610-617DOI: (10.1016/j.jvs.2005.01.013) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions
Fig 3 Neutrophil counts in patients with and without major adverse cardiovascular events (MACE) according to the presence of increasing numbers of the atherothrombotic risk factors of smoking, hyperlipidemia, arterial hypertension, and diabetes mellitus. Journal of Vascular Surgery 2005 41, 610-617DOI: (10.1016/j.jvs.2005.01.013) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions